Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Watertown, Massachusetts
- Most recent report
- 8-K, filed Oct 29, 2026
- Incorporated
- N/A
- Filings on record
- 835 filings
- On EDGAR
- CIK 1177648
- Fiscal year ends
- September
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 55
News 8 of 117
Prospectuses and Registrations 8 of 28
- 424B5 Prospectus supplement for an offering Jul 2, 2026
- S-8 Registration statement for an employee plan May 13, 2026
- S-3 Shelf registration statement Feb 11, 2026
- 424B5 Prospectus supplement for an offering Oct 1, 2025
- 424B5 Prospectus supplement for an offering Sep 30, 2025
- S-8 Registration statement for an employee plan May 14, 2025
- S-8 Registration statement for an employee plan May 8, 2024
- S-3 Shelf registration statement Nov 22, 2023
Proxies 8 of 24
- DEFA14A Extra proxy material Jan 26, 2026
- DEF 14A Proxy statement for a shareholder vote Jan 26, 2026
- DEFA14A Extra proxy material Jan 27, 2025
- DEF 14A Proxy statement for a shareholder vote Jan 27, 2025
- DEFA14A Extra proxy material Jan 26, 2024
- DEF 14A Proxy statement for a shareholder vote Jan 26, 2024
- DEFA14A Extra proxy material Jan 20, 2023
- DEF 14A Proxy statement for a shareholder vote Jan 20, 2023
Ownership 8 of 576
- SCHEDULE 13G Large holder reported a passive stake Oct 27, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 4 Insider reported a trade Aug 10, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Mar 26, 2026
- 4 Insider reported a trade Mar 13, 2026
- 4 Insider reported a trade Mar 13, 2026
- 4 Insider reported a trade Mar 13, 2026
Other 8 of 35
- EFFECT Notice that a registration became effective Feb 20, 2026
- CORRESP Reply to SEC staff Feb 17, 2026
- UPLOAD Comment letter from SEC staff Feb 17, 2026
- ARS Annual report sent to shareholders Jan 26, 2026
- ARS Annual report sent to shareholders Jan 27, 2025
- UPLOAD Comment letter from SEC staff Feb 26, 2024
- CORRESP Reply to SEC staff Feb 14, 2024
- EFFECT Notice that a registration became effective Feb 8, 2024
Everything here comes from Enanta Pharmaceuticals Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.